entecavir
Showing 26 - 50 of 136
Hepatitis B, Chronic Trial in Pokfulam, Shatin (ARC-520, Placebo, entecavir)
Hepatitis B, Compensated Cirrhosis Trial in Guangzhou (Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir alafenamide)
Recruiting
- Hepatitis B
- Compensated Cirrhosis
- Entecavir
- +2 more
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital of Sun Yat-sen University
Dec 10, 2019
Hepatitis B Infection, Malignant Solid Tumor Trial in Guam, United States (Best Practice, Entecavir, Tenofovir Alafenamide)
Recruiting
- Hepatitis B Infection
- Malignant Solid Neoplasm
- Best Practice
- +3 more
-
Fort Smith, Arkansas
- +192 more
Apr 4, 2022
Chronic Hepatitis B Trial in China (biological, drug, other)
Completed
- Chronic Hepatitis B
- Therapeutic HBV vaccine
- +2 more
-
Hefei, Anhui, China
- +14 more
Mar 31, 2019
Rheumatoid Arthritis, Hepatitis B Reactivation, Exposure to Hepatitis B Virus Trial in Taipei (Entecavir)
Unknown status
- Rheumatoid Arthritis
- +2 more
- Entecavir
-
Taipei, TaiwanDivision of Gastroenterology & Division of Allergy Immunology an
Mar 11, 2019
Colorectal Tumors Trial in Guangzhou (Entecavir)
Unknown status
- Colorectal Neoplasms
- Entecavir
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jan 17, 2019
Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for
Unknown status
- Hepatitis B, Chronic
- +2 more
- Entecavir
- Tenofovir Disoproxil
-
Shanghai, Shanghai, ChinaRui Jin Hospital Affiliated to Shanghai Jiao Tong University Sch
Nov 10, 2019
Chronic Hepatitis B Trial in Taipei (Engerix-B, Tenofovir, Entecavir)
Completed
- Chronic Hepatitis B
- Engerix-B
- +2 more
-
Taipei, TaiwanChang Gung Memorial Hospital
Jul 28, 2019
Nucleos(t)Ide Analogues in Treatment of HBV-related
Unknown status
- Hepatitis B
- +2 more
- Tenofovir Alafenamide
- +2 more
-
Ankang, China
- +10 more
May 2, 2019
Chronic Hepatitis B Virus, Pediatric Trial in Worldwide (Entecavir, Placebo)
Completed
- Chronic Hepatitis B Virus, Pediatric
- Entecavir
- Placebo
-
San Francisco, California
- +43 more
Apr 16, 2019
Hepatitis B, Acute-On-Chronic Liver Failure Trial in Guangzhou (Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide)
Recruiting
- Hepatitis B
- Acute-On-Chronic Liver Failure
- Entecavir
- +2 more
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital of Sun Yat-sen University
Apr 17, 2019
Chronic Hepatitis B Trial in Russian Federation (Entecavir, Myrcludex B)
Completed
- Chronic Hepatitis B
- Entecavir
- Myrcludex B
-
Chelyabinsk, Russian Federation
- +8 more
Dec 28, 2017
HBV Trial in Nedlands (Entecavir)
Completed
- HBV
- Entecavir
-
Nedlands, Western Australia, AustraliaLinear Clinical Research Ltd
Jun 25, 2018
Chronic Viral Hepatitis B Without Delta-agent Trial in Seoul (Tenofovir, Entecavir)
Completed
- Chronic Viral Hepatitis B Without Delta-agent
- Tenofovir
- Entecavir
-
Seoul, Korea, Republic ofAsan Medical Center
May 8, 2018
Hepatitis B, Chronic Trial in Seoul (Peginterferon alfa-2a, HBV vaccination, Entecavir)
Completed
- Hepatitis B, Chronic
- Peginterferon alfa-2a
- +2 more
-
Seoul, Korea, Republic ofSeoul National University
May 3, 2018
Chronic Hepatitis b Trial in Shanghai (Thymosin Alpha1, Entecavir)
Unknown status
- Chronic Hepatitis b
- Thymosin Alpha1
- Entecavir
-
Shanghai, Shanghai, ChinaHuashan Hospital of Fudan University
Feb 22, 2018
Hepatitis B Trial in Grafton (ARC-521 Injection, Placebo, antihistamine)
Terminated
- Hepatitis B
- ARC-521 Injection
- +5 more
-
Grafton, Auckland, New ZealandAuckland Clinical Studies Ltd
Jan 10, 2018
Hepatitis B, Hepatitis D Trial in Worldwide (ARC-520, entecavir, pegylated interferon alpha 2a)
Terminated
- Hepatitis B
- Hepatitis D
- ARC-520
- +4 more
-
Camperdown, New South Wales, Australia
- +32 more
Jan 11, 2019